Correlation Between Achilles Therapeutics and Aadi Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Aadi Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Aadi Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Aadi Bioscience, you can compare the effects of market volatilities on Achilles Therapeutics and Aadi Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Aadi Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Aadi Bioscience.

Diversification Opportunities for Achilles Therapeutics and Aadi Bioscience

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Achilles and Aadi is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Aadi Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aadi Bioscience and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Aadi Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aadi Bioscience has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Aadi Bioscience go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Aadi Bioscience

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.68 times more return on investment than Aadi Bioscience. However, Achilles Therapeutics PLC is 1.47 times less risky than Aadi Bioscience. It trades about 0.15 of its potential returns per unit of risk. Aadi Bioscience is currently generating about -0.13 per unit of risk. If you would invest  118.00  in Achilles Therapeutics PLC on December 29, 2024 and sell it today you would earn a total of  30.00  from holding Achilles Therapeutics PLC or generate 25.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.43%
ValuesDaily Returns

Achilles Therapeutics PLC  vs.  Aadi Bioscience

 Performance 
       Timeline  
Achilles Therapeutics PLC 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Aadi Bioscience 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aadi Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Achilles Therapeutics and Aadi Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Achilles Therapeutics and Aadi Bioscience

The main advantage of trading using opposite Achilles Therapeutics and Aadi Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Aadi Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will offset losses from the drop in Aadi Bioscience's long position.
The idea behind Achilles Therapeutics PLC and Aadi Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal